The number one way to learn about the market
Investing doesn't have to be as hard as you think. With one email a day, you'll learn everything you need to know to make better choices with your money. See how over a million people are taking control of their wealth.
Proudly Featured In
Learn from the experts
Tap into our network of experienced analysts. From former hedge fund managers, multi-billion-dollar pension fund managers, advisors, traders, professors, accountants, financial lawyers, inventors and doctors, there's not a corner of the market we can't help you understand.
Our team will show you the best ways to protect and grow your money no matter what's happening in the market. We'll be with you every step of the way regardless of your starting point, your risk tolerance or your financial interests. You're guaranteed to find something you like.
Subscribers Worldwide
1M+
Editors & Analysts
33
No. of Products
31
No. of 10x Recommendations
24
Find what works for you
Whether you're just starting out or a seasoned professional, there's something for everyone. Each one of our 30+ research services are designed to protect and grow your wealth.
Join the 1M+ people growing their wealth with Stansberry Research
Given me an edge
Stansberry Research has given me an edge in facing the ever-changing times we are in - not everyone has found it as easy. Thank you, you do a great job.
Mervyn D.
Subscriber since 2013
Cashed out with about a 500% gain
We recently cashed out with about a 500% gain. You do good work. We're a retired couple, on a fixed income, so getting the growth in the IRA is very helpful.
David B.
Subscriber since 2000
Broadened my knowledge
Stansberry Research has broadened my knowledge in so many areas, including options and short sales that I never imagined I'd do. The recommended investments are so comprehensive, I love it!
Laura P.
Subscriber since 2015
I'm richer, smarter, and wiser
I have two degrees, an MBA, and PhD, and I have learned more about business and finance through Stansberry than all my degrees combined. I'm richer, smarter, and wiser today because of you.
Adriano R.
Subscriber since 2013
The means to achieve financial independence
I know the success I have had in the last three months, managing my own financial account and making gains during challenging times is due to the outstanding work and recommendations of Stansberry Research and the availability and support of the team. Partnering with Stansberry has given me the means to achieve financial independence.
Linda
Subscriber since 2020
Returns speak for themselves
I have been a member for years now and am a professional advisor, but I can't express my gratitude any more than looking at the returns I have generated this year by being an avid reader of all your newsletters. These returns speak for themselves. I can't thank you enough and feel honored to have found your services a few years back.
Pete C.
Subscriber since 2015
In the Stansberry Innovations Report, editor Eric Wade and our team of technology experts focus on the most pioneering and disruptive technologies around the world today.
The team looks for early opportunities in new technology trends that span the medical sciences, biotechnology, software, hardware, defense, and cryptocurrencies. These trends will likely play out over several years and decades.
Eric Wade
Editor
Largest Gain of Closed Position
446%
No. of 100%+ Winners
6
Model Portfolio Return vs S&P 500
+10.3%
Publication Overview
Publishing Schedule
Monthly (third Friday of every month) with email updates as needed
Required Capital
Approx. $1000 / Great for beginning investors, retirees, and those planning for retirement
Risk Tolerance
Conservative
Everything you need, all in one place
Nearly 1 in 2 Americans think they don't have enough money to enjoy retirement. We're changing the game. Sign up to get our best ideas every day the market's open.
Trending financial news
We watch the markets 24 hours a day, 365 days a year so you don't have to. Check out the latest issue of The Stansberry Digest, our flagship newsletter.
Risk Is Out, 'Real' Is In
Seeking peace in Switzerland... The market is churning... The Mag 7 are down 10%... What's winning instead... A 'top' defined by AI... The $1 trillion software panic... A land of opportunity...
Two wars, one city to end them both?...
Negotiators from the Trump administration are in Geneva, Switzerland... There, they met today with representatives of Russia, Ukraine, and Iran in hopes of ending multiple yearslong global conflicts.
News from the Ukraine talks didn't reveal much movement. The two sides remain at odds over control of disputed territory and the possibility of security guarantees for Ukraine.
The Iranian negotiations showed more promise...
Ahead of the talks, U.S. and Iranian leaders postured by positioning military capabilities in the Middle East. And Iran closed part of the Strait of Hormuz earlier today, a waterway heavily trafficked by oil tankers.
The U.S.'s Steve Witkoff and Jared Kushner, the president's son-in-law, met with Iranian officials first. After those
Keep reading with a free account
Get access to the full article, plus access to our entire archive when you enter your email below.
This Simple Tool Could Help You Find the Next Amazon
Feb 18, 2026
Editor's note: Software stocks have taken a tumble recently. And for the folks struggling to pick through the wreckage of today's software space, Joe Austin of our corporate affiliate Chaikin Analytics offers a solution... In today's piece, updated from a recent issue of the free Chaikin PowerFeed e-letter, Joe explains the simple formula investors can use to spot the companies that can follow through on their growth promises.Jeff Bezos once said that "overnight success" takes about 10 years...
Keep reading...
Don't Count Software Out Just Yet
Feb 18, 2026
The message the market sent while obliterating software stocks around the world this month is unmistakable...No sector is safe from a sudden reset or quick repricing.
Keep reading...
Episode 452: 10:1 Risk/Reward: 3 Drug Monopolies Built for Massive Upside
Feb 16, 2026
In this week's Stansberry Investor Hour, Dan and John Engel welcome Dave Lashmet to the show. Dave is the editor of Stansberry Venture Technology, an advisory that takes a "venture capitalist" look at the market. Dave scours the market looking for little-known small-cap companies that are potentially producing the next wonder drug or technology.Dave kicks things off by discussing the first of three biopharmaceutical companies he's sharing that have monopolies in weight-loss drugs. He starts by showing how drugs gain their monopolies via patents, giving them "economic exclusivity." While companies might be targeting the same patients, the patents influence how they're being treated. The first company gains an edge by not only targeting folks suffering from obesity, but also by treating those with Type 2 diabetes. Dave also explains the contrast in mentality between the U.S. and other countries regarding obesity being preventable. And he provides info showing how obesity is a "slippery slope" and shares that a study found that participants who got off the drug gained back the weight they lost before...
Listen to the episode
Investing lessons from Guy Spier's annual letter and my unpublished book
Feb 18, 2026
In yesterday's e-mail, I shared excerpts from my friend Guy Spier's final annual letter. (You can read all 15 pages here.) After 26 years, he's closing his hedge fund, Aquamarine Capital, because he's battling grade 4 glioblastoma (brain cancer).The few sections I shared yesterday were on life lessons. Today, I want to highlight some of his wise investing lessons. Pay attention, because Guy generated a market-beating return of 1,185.6% for his hedge fund...
Keep reading...
